Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Alexandra, Mangili"'
Autor:
Sujata P. Sarda, Magdalena Vanya, Ethan J. Schwartz, Keira Sorrells, Fumihiko Namba, Shinya Hirano, Alison McNulty, Linda Han, Alexandra Mangili
Publikováno v:
Biomedicine Hub, Vol 8, Iss 1, Pp 15-24 (2023)
Introduction: Extremely premature (EP) infants (
Externí odkaz:
https://doaj.org/article/ebaee3cd1ff3411fa4b04a2db191703c
Autor:
Sandra Horsch, Alessandro Parodi, Boubou Hallberg, Mariya Malova, Isabella M. Björkman-Burtscher, Ingrid Hansen-Pupp, Neil Marlow, Kathryn Beardsall, David Dunger, Mirjam van Weissenbruch, Lois E. H. Smith, Mohamed Hamdani, Alexandra Mangili, Norman Barton, Luca A. Ramenghi, Ann Hellström, David Ley, ROPP-2008-01 Study Team
Publikováno v:
Frontiers in Pediatrics, Vol 8 (2020)
Background: Postnatal insulin-like growth factor-1 (IGF-1) replacement with recombinant human (rh)IGF-1 and IGF binding protein-3 (rhIGF-1/rhIGFBP-3) is being studied as a potential treatment to reduce comorbidities of prematurity. We have recently r
Externí odkaz:
https://doaj.org/article/4c47f74bcd024965bb4acccc525a64da
Publikováno v:
Frontiers in Pediatrics, Vol 7 (2019)
Background: Infants born extremely preterm are at high risk of developing bronchopulmonary dysplasia (BPD). This study aimed to assess the incremental health care burden of BPD and associated comorbidities among extremely preterm infants in the Unite
Externí odkaz:
https://doaj.org/article/7427ee10dd2d4d45961c90ca8cba6846
Autor:
Robin H. Steinhorn, Magdalena Vanya, Sujata P. Sarda, L. Han, Hugh O'Brodovich, Ethan J. Schwartz, Ellen M Janssen, Robert M. Ward, Alexandra Mangili, Mikko Hallman
Publikováno v:
Pediatric Pulmonology
Objective Chronic lung disease of prematurity (CLDP) is a frequent complication of prematurity. We aimed to identify what clinicians believe are the most important factors determining the severity of CLDP in extremely preterm infants (
Autor:
David Ley, Alex Adusei Agyemang, Norman W. Barton, Bo Holmqvist, Suvi Vallius, Galen Carey, Xiaoyang Wang, Ann Hellström, Lois E.H. Smith, Claes Ekström, Alexandra Mangili, Magnus Gram, William Hellström, Niklas Ortenlöf
Publikováno v:
Developmental neuroscience
Following preterm birth, serum levels of insulin-like growth factor 1 (IGF-1) decrease compared to corresponding in utero levels. A recent clinical trial indicated that supplementation with recombinant human (rh) IGF-1/rhIGF-binding protein 3 (rhIGF-
Autor:
Rajeev Ayyagari, Jessie Wang, Wei Gao, Meredith E. Mowitz, L. Han, Alexandra Mangili, Jing Zhao, Sujata P. Sarda
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 21:1117-1125
Objective: To evaluate the prevalence of chronic respiratory morbidity (CRM) in preterm infants (born ≤28 weeks gestational age (GA)) and compare healthcare resource utilization and costs among inf...
Autor:
Thomas Salaets, Jonathan M. Davis, Michael D. Blum, Hidefumi Nakamura, Joseph G. Toerner, Susan McCune, Susan Tansey, Mary A Short, Ron Portman, Alexandra Mangili, Agnes Klein, Junko Sato, Barry Mangum, Laura Fabbri, Gerri Baer, Mark A. Turner, Isamu Hokuto, Karel Allegaert, Lynne Yao
Publikováno v:
Journal of Pediatrics, 219, 243-249. Mosby Inc.
ispartof: JOURNAL OF PEDIATRICS vol:219 pages:243-+ ispartof: location:United States status: published
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140358 (2015)
Tesamorelin, a synthetic analog of human growth hormone-releasing factor, decreases visceral adipose tissue (VAT) in human immunodeficiency virus (HIV)-infected patients with lipodystrophy.1) To evaluate the utility of patient characteristics and val
Externí odkaz:
https://doaj.org/article/3021d059ba47406b88138236a6df3d60
Autor:
Todd Hulgan, M. Sean Boger, Diana H. Liao, Grace A. McComsey, Christine A. Wanke, Alexandra Mangili, Sharon L. Walmsley, Heather McCreath, Ginger L. Milne, Stephanie C. Sanchez, Judith S. Currier, Jordan E. Lake
Publikováno v:
Mediators of Inflammation, Vol 2014 (2014)
Chronic inflammation is a hallmark of HIV infection. Eicosanoids reflect inflammation, oxidant stress, and vascular health and vary by sex and metabolic parameters. Raltegravir (RAL) is an HIV-1 integrase inhibitor that may have limited metabolic eff
Externí odkaz:
https://doaj.org/article/227e6860e56f457d82388766b2fc0812
Publikováno v:
9th ICCN International Conference on Clinical Neonatology—Selected Abstracts.